文献速递肥胖与代谢综合征

瘦素-黑素皮质素通路杂合变异与重度肥胖的关系

Implication of Heterozygous Variants in Genes of the Leptin-Melanocortin Pathway in Severe Obesity.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该回顾性研究对1486例重度肥胖先证者(600例儿童、886例成人)进行LEP、LEPR、POMC和PCSK1基因分型,分析杂合与纯合变异的频率及表型。结果显示杂合变异频率为6.7%(n=100),纯合变异为1.7%(n=26);成人纯合变异者BMI更高、肥胖发病更早、食物冲动性和内分泌异常更常见,高影响杂合变异及通路第二杂合变异者BMI也更高。结论提示杂合变异在重度肥胖中常见,部分表型接近纯合变异。

要点

  • 重度肥胖者中LEP/LEPR/POMC/PCSK1杂合变异频率为6.7%,纯合变异为1.7%。
  • 成人纯合变异者BMI更高(66 vs 53 kg/m²)、肥胖发病更早(0.4 vs 5.4岁)。
  • 高影响杂合变异及通路第二杂合变异者BMI更高,儿童中无显著差异。

核心结论

  • LEP、LEPR、POMC和PCSK1杂合变异在重度肥胖中常见,有时与接近纯合变异者的表型相关。
  • 数据提示对重度早发性肥胖应系统筛查该通路变异,以讨论靶向该通路的治疗。

研究设计与样本

  • 回顾性研究,对1486例重度肥胖先证者(600例儿童、886例成人)进行至少一个LEP、LEPR、POMC和PCSK1基因分型。
  • 在60例杂合变异者和16例纯合变异者中收集表型,分析变异频率、BMI、肥胖发病年龄、食物冲动性和内分泌异常。

主要发现

  • 纯合变异者频率为1.7%(n=26),杂合变异者为6.7%(n=100)。
  • 儿童中肥胖发病年龄和BMI无显著差异。

临床怎么用

  • 对重度早发性肥胖可考虑系统筛查LEP、LEPR、POMC和PCSK1变异。
  • 检出杂合变异时需评估是否携带通路第二变异及变异影响程度,以判断表型风险。
  • 针对瘦素-黑素皮质素通路的治疗讨论可基于基因筛查结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Unlike homozygous variants, the implication of heterozygous variants on the leptin-melanocortin pathway in severe obesity has not been established. OBJECTIVE: To describe the frequency, the phenotype, and the genotype-phenotype relationship for heterozygous variants in LEP, LEPR, POMC, and PCSK1 in severe obesity. METHODS: In this retrospective study, genotyping was performed on at least 1 of the LEP, LEPR, POMC, and PCSK1 genes in 1486 probands with severe obesity (600 children, 886 adults). The phenotype was collected in 60 subjects with heterozygous variants and 16 with homozygous variants. We analyzed variant frequency, body mass index (BMI), age of obesity onset, food impulsivity, and endocrine abnormalities. RESULTS: The frequency of subjects with homozygous variants was 1.7% (n = 26), and 6.7% (n = 100) with heterozygous variants. Adults with homozygous variants had a higher BMI (66 vs 53 kg/m2, P = .015), an earlier onset of obesity (0.4 vs 5.4 years, P < .001), more often food impulsivity (83% vs 42%, P = .04), and endocrine abnormalities (75% vs 26%, P < .01). The BMI was higher for subjects with high-impact heterozygous variants (61 vs 50 kg/m², P = .045) and those with a second heterozygous variant on the pathway (65 vs 49 kg/m², P < .01). In children, no significant differences were found for the age of obesity onset and BMI. CONCLUSION: Heterozygous variants in LEP, LEPR, POMC, and PCSK1 are frequent in severe obesity and sometimes associated with a phenotype close to that of homozygotes. These data suggest a systematic search for variants in severe early-onset obesity, to discuss therapy that targets this key pathway.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Courbage S, Poitou C, Le Beyec-Le Bihan J, et al. Implication of Heterozygous Variants in Genes of the Leptin-Melanocortin Pathway in Severe Obesity. J Clin Endocrinol Metab. 2021. PMID: 34097736. doi:10.1210/clinem/dgab404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。